A follow up study conducted at the Seattle Children’s Hospital of children suffering myocarditis following their second dose of the Pfizer mRNA vaccine was published in the Journal of Pediatrics on 25 March 2022.
The study followed up 16 male children, with an average age of 15 years, 3 to 8 months after their initial diagnosis with myocarditis within a short time frame following mRNA vaccination.
The authors used Electrocardiograms and Cardiac Magnetic Resonance (CMR) to examine abnormalities in the heart such as myocardial scarring, fibrosis, strain, and reduced ventricular muscle extension which can be associated with reduced capacity to pump blood and increased risk of heart attack.
The authors found that although there was some measure of resolution after 3 – 8 months most subjects still had some persistent abnormalities.
“Although (initial) symptoms (such as chest pain, and exercise intolerance) were transient and most patients appeared to respond to treatment (solely with NSAIDS such as ibuprofen), we demonstrated persistence of abnormal findings on CMR at (3-8 months) follow up in most patients, albeit with improvement in extent of LGE (a measure of the heart’s capacity to pump efficiently).”
The authors warned:
“The presence of LGE is an indicator of cardiac injury and fibrosis and has been strongly associated with worse prognosis in patients with classical acute myocarditis. A meta-analysis including 8 studies found that presence of LGE is a predictor of all cause death, cardiovascular death, cardiac transplant, rehospitalization, recurrent acute myocarditis and requirement for mechanical circulatory support.”
For those who wish to review a detailed evaluation of this study by a medical expert, you can watch this video –
Wider implications for New Zealand
The latest Medsafe Adverse Effects Report #41 lists 12,000 people who have experienced chest discomfort and 6,000 shortness of breath (all ages) following mRNA vaccination, both classic symptoms of myocarditis. The authors of the small study reported above concluded:
“In the cohort of adolescents with COVID-19 mRNA vaccine-related myopericarditis, a large portion have persistent LGE abnormalities, raising concerns for potential longer-term effects.”
It is clear that little has been done in New Zealand to follow up those affected by adverse effects. Many reporting to EDs or GPs with chest pain, tachycardia, or shortness of breath have been told that everything will be OK without clinical assessment. In many cases these symptoms were not even registered with CARM.
Even though the Seattle study had few participants, it red flags the possibility of subsequent cardiac events. It raises the possibility that sub clinical adverse effects of mRNA vaccination may have serious longer term impacts on health. Until now these have been classified as non-serious in NZ. Persistent reports of cardiac events in the weeks and months following mRNA vaccination among ostensibly fit and healthy people of all age groups and genders, but especially men, can no longer be ignored or dismissed as unrelated. They need to be investigated.
This underlines the fact that the Pfizer mRNA vaccination roll out has been undertaken in the absence of long term follow up testing which often requires the use of sophisticated equipment such as CMR and MRI. Moreover heart disease is not the only category of serious illness whose incidence may be increased by mRNA vaccination as other recent studies suggest. Possible long term adverse effects include cancer, kidney and liver disease, and neurological conditions. A recent court-ordered document release shows Pfizer and probably our government is aware of cases.
But our government is still persisting with advertising suggesting that mRNA vaccination is safe and effective. This is not supported by research. mRNA vaccination comes with some serious risks. Moreover the government was well aware of the risks from the start. In an internal document released under OIA dated 10th February 2021 and signed by Ashley Bloomfield, Director General of Health and Chris Hipkins, Covid Response Minister discussing provisions for the vaccination of border workers, point 57 says:
“current data suggests severe adverse reactions are less than 1.1%”
Following 10 million injections, as we have had in NZ, that would amount to more than 100,000 adverse reactions (a figure not inconsistent with the grossly under reported 55,000 adverse reactions registered with CARM). Did either Ashley Bloomfield, Jacinda Ardern, or Chris Hipkins ever hint to the public or the media that this was the expected outcome? No they did not. They told the public the vaccine was completely safe and effective. They hid facts.